Swiss Financial Market Supervisory Authority FINMA fully dismissed appeals of Kun Shen, Mengke Cai, Xu Xiang, Himalaya (Cayman Island) TMT Fund, and Himalaya Asset Management Ltd. against TOB decision – voting rights of said parties again suspended

Tel Aviv / Zurich, 26 November 2018 – SHL Telemedicine Ltd. (SIX Swiss Exchange: SHLTN) (“SHL”), a leading provider and developer of advanced personal telemedicine solutions, announced today that on 23 November 2018 the Swiss Financial Market Supervisory Authority FINMA resolved to reject the appeals of Kun Shen, Mengke Cai, Xu Xiang, Himalaya (Cayman Island) TMT Fund, and Himalaya Asset Management Ltd. against the decision of the Swiss Takeover Board (TOB) of 1 September 2018 (decision 672/04). As a consequence of the decision of FINMA, the voting rights of Kun Shen, Mengke Cai, Xu Xiang, Himalaya (Cayman Island) TMT Fund, and Himalaya Asset Management Ltd. are suspended until a mandatory tender offer is published, and no further deadline for the launch of a mandatory tender offer is granted to the appellants. The parties may appeal against this decision of FINMA within 10 calendar days. For more information Click here